Biofrontera (BFRI) Change in Accured Expenses (2020 - 2025)
Biofrontera has reported Change in Accured Expenses over the past 6 years, most recently at -$1.7 million for Q4 2025.
- For Q4 2025, Change in Accured Expenses fell 321.32% year-over-year to -$1.7 million; the TTM value through Dec 2025 reached $610000.0, up 365.22%, while the annual FY2025 figure was $610000.0, 365.22% up from the prior year.
- Change in Accured Expenses for Q4 2025 was -$1.7 million at Biofrontera, down from $746000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $6.2 million in Q3 2023 and troughed at -$12.5 million in Q4 2023.
- A 5-year average of -$291600.0 and a median of $57500.0 in 2021 define the central range for Change in Accured Expenses.
- Biggest five-year swings in Change in Accured Expenses: soared 4114.63% in 2022 and later tumbled 379.02% in 2023.
- Year by year, Change in Accured Expenses stood at -$1.1 million in 2021, then plummeted by 141.17% to -$2.6 million in 2022, then tumbled by 379.02% to -$12.5 million in 2023, then surged by 96.84% to -$394000.0 in 2024, then plummeted by 321.32% to -$1.7 million in 2025.
- Business Quant data shows Change in Accured Expenses for BFRI at -$1.7 million in Q4 2025, $746000.0 in Q3 2025, and $1.2 million in Q2 2025.